Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab.
Barth AS, Zhang Y, Li T, Smith RR, Chimenti I, Terrovitis I, Davis DR, Kizana E, Ho AS, O'Rourke B, Wolff AC, Gerstenblith G, Marbán E.
Barth AS, et al. Among authors: zhang y.
Stem Cells Transl Med. 2012 Apr;1(4):289-97. doi: 10.5966/sctm.2011-0016. Epub 2012 Apr 10.
Stem Cells Transl Med. 2012.
PMID: 23197808
Free PMC article.
Clinical Trial.